Search Videos and More
Symposium
23rd Annual Highlights of the 2024 San Antonio Breast Cancer Symposium
Presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education, this education program is designed to help medical, radiation, and surgical oncologists, gynecologists, and radiologists translate the data from key presentations of the 2024 San Antonio Breast Cancer Symposium into practice. New options for the prevention, diagnosis, and treatment of breast cancer and premalignant breast disease will be discussed. In addition, we will address new strategies for optimizing existing treatments.
Video
Transforming Treatment for Chronic Lymphocytic Leukemia Patients
Over the past 10 years, the treatment landscape and prognosis for Chronic Lymphocytic Leukemia (CLL) has dramatically improved, even among older adults.
News
GYNECOLOGIC CANCER PROGRAM
Comprehensive Care That Empowers Patients Through Risk Assessment, Prevention, Detection, Treatment, and Survivorship
Video
Complex Patient Case Review for Oncologic and Benign Urology
The Fox Chase–Temple Urologic Institute delivers expert care for both complex oncologic and benign urologic conditions. Backed by a team of renowned urologic specialists, we are recognized regionally and internationally for offering innovative, leading-edge treatments.
News
Fox Chase Cancer Center Fellow Dr. Joseph Van Galen Awarded American Society of Clinical Oncology Young Investigator Award
Joseph Van Galen, MD, MS, Chief Fellow in the Hematology/Oncology Fellowship Program at Fox Chase Cancer Center
News
Married People May Have Better Colorectal Cancer Outcomes, Fox Chase Cancer Center Study Shows
Namrata Vijayvergia, MD, Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center
News
Electronic Health Record Intervention Boosts Fertility Preservation for Young Cancer Patients at Fox Chase Cancer Center
Christopher Cann, MD, Director of the Young Adult Cancer Program and Assistant Professor in the Department of Hematology/Oncology at Fox Chase Cancer Center
Course
Complex Patient Case Review for Oncologic and Benign Urology
Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025
News
New Fox Chase Cancer Center Study Shows Partially Absorbable Mesh Significantly Lowers Parastomal Hernia Risk Following Bladder Removal
Parastomal hernia is a common complication among patients who undergo bladder removal and ileal conduit urinary diversion. Now, a new study “Very Low Rate of Parastomal Hernia Using Partially Absorbable Macroporous Mesh for Prophylactic Reinforcement in Ileal Conduit Urinary Diversion: A Collaborative Approach Between Urology and Plastic/Reconstructive Surgery,” presented by Fox Chase Cancer Center clinicians at the American Urological Association’s (AUA) 2025 Annual Meeting supports the use of partially absorbable synthetic, non-biologic parastomal mesh to significantly reduce this risk in real-world practice.
News
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds
Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.
News
Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer
Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.
News
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy
Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.